PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
30-May-2024 Artificial Intelligence in Oncology Market to Grow at Unprecedented 35% CAGR, Reaching USD 13.6 Billion by 2032 Wired Release
30-May-2024 Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders Relief Therapeutics Holding SA
30-May-2024 Liver Cancer Drugs Market Projected to Grow at 9.3% CAGR, Reaching USD 2.3 Billion by 2032 Wired Release
30-May-2024 PET Scanners Market to Surge to USD 3,595.7 Million by 2032, Driven by Rising Chronic Disease Incidence Wired Release
29-May-2024 Physicians in the US and UK believe Pfizer is leading the industry in AI/Machine Learning in drug discovery – But which big pharma company is most trusted to use the technology safely? Bryter Inc.
29-May-2024 Au Pair USA Expands International Au Pair Program in Georgia and Other New Service Areas AccessWire
29-May-2024 Asymchem Welcomes Franck Mevellec as Senior Director, Business Development Asymchem
29-May-2024 The Department of Health – Abu Dhabi and Eli Lilly Suisse S.A to collaborate to advance Neurodegenerative Disease patient care in the Emirate The Department of Health – Abu Dhabi
29-May-2024 Lexicon Pharmaceuticals Selects Medidata to Help Advance First Non-Opioid Drug for Neuropathic Pain in Over Two Decades Lexicon Pharmaceuticals
29-May-2024 Kindeva Global Health Security Donates ATNAA to Ukraine Through the European Commission’s rescEU and Governmental Strategic Reserves Agency (RARS) Kindeva Drug Delivery
29-May-2024 ScaleReady announces $20 Million G-Rex® grant program for the advancement of cell and gene therapy (CGT) development and manufacturing CellReady LLC
29-May-2024 NowPatient Expands Services with Pharmacogenetics Testing Deals in the US and Germany NowPatient
29-May-2024 Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline Adcendo ApS
29-May-2024 Resolution Therapeutics Announces Upcoming Scientific Presentations at EASL Congress 2024 Resolution Therapeutics
29-May-2024 Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline Adcendo
29-May-2024 Kromek Group plc - FY 2024 Trading Update Kromek Group plc
29-May-2024 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study Anaveon
29-May-2024 Almac Group announces record revenue figure resulting from another year of growth. Revenue reaches $1.169 billion with profit at $114.4 million Almac Group
29-May-2024 Integrated Biosciences Collaborate with Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome Integrated Biosciences
29-May-2024 Novo Holdings portfolio company Numab Therapeutics announces Johnson & Johnson (‘J&J’) to acquire its wholly-owned subsidiary Yellow Jersey Therapeutics, including rights to NM26, a bi-specific antibody for the treatment of atopic dermatitis Novo Holdings